Identification of Pimavanserin Tartrate as a Potent Ca²⁺-Calcineurin-NFAT Pathway Inhibitor for Glioblastoma Therapy

Researchers carried out research to discover a novel alternative drug targeting the oncogenic NFAT signaling pathway for Glioblastoma multiforme therapy.